ProS1-MerTK signaling in CD4 T cells: implications for TIL expansion and functionality
Cancer immunotherapy predominantly targets CD8 T cells, but recent evidence highlights the importance of CD4 T cells in adoptive cell therapy (ACT). The TAM receptor MerTK regulates immune responses and has been shown to provide costimulatory signals in CD8 T cells. However, its role in CD4 T cells...
Saved in:
| Main Authors: | Annina Kurzay, Sara Fresnillo Saló, Anne Rahbech, Tina Seremet, Cecilie Oelvang Madsen, Christopher Aled Chamberlain, Emilie Bülow Jensen, Viet Thy Luu, Özcan Met, Marlies J W Peeters, Per thor Straten |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | OncoImmunology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2025.2532662 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Downregulation of MerTK in circulating T cells of patients with non-proliferative diabetic retinopathy
by: Shimiao Bu, et al.
Published: (2025-01-01) -
PROS1‐MERTK Axis Drives Tumor Microenvironment Crosstalk and Progression in Papillary Thyroid Microcarcinoma
by: Wenqian Zhang, et al.
Published: (2025-08-01) -
AXL in myeloid malignancies – an elusive target?
by: Pia Aehnlich, et al.
Published: (2024-12-01) -
Expression pattern and clinical significance of MerTK on circulating NK cells in systemic lupus erythematosus
by: Jianping Guo, et al.
Published: (2025-06-01) -
MerTK inhibitor suppresses melanoma growth in mice by regulating the quantity and phenotype of tumor-associated macrophages
by: WU Naming, et al.
Published: (2025-07-01)